Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Why Estimates of Future Revenues for Obesity Drugs Are Likely Off the Mark
BNET Pharma
Monday, October 19, 2009 - 6:43pm
tags:
obesity, Qnexa, Vivus, Arena Pharmaceuticals, Orexigen, Contrave
Genentech brand to replace Roche in U.S.
Fierce Pharma
Monday, October 19, 2009 - 6:41pm
tags:
Genentech, Roche
Merck starts revealing payments to doctor-speakers
Yahoo/AP
Monday, October 19, 2009 - 6:37pm
tags:
Merck, physician payments
Baxter Eyes Swine Flu Market
Yahoo/Zacks.com
Monday, October 19, 2009 - 6:35pm
tags:
vaccines, swine flu, H1N1, Baxter International
Amgen: Still Waiting for Its Blockbuster
Motley Fool
Monday, October 19, 2009 - 6:32pm
tags:
denosumab, Amgen, Prolia, osteoporosis
Earnings Preview: Pfizer
Seeking Alpha
Monday, October 19, 2009 - 6:32pm
tags:
earnings, Pfizer
Endo to respond to FDA questions on Fortesta by mid-2010
Bizjournals.com
Monday, October 19, 2009 - 6:30pm
tags:
Endo, Foretesta, FDA, testosterone
GSK faces Merck in vaccine price war
FT.com
Monday, October 19, 2009 - 6:26pm
tags:
GSK, vaccines, Merck, Gardasil, Cervarix, HPV
New Pfizer Animal Health is Unveiled with Acquisition of Wyeth
Yahoo
Monday, October 19, 2009 - 6:25pm
tags:
animal health, reorganization, Wyeth, Pfizer
Drug stocks split; Amgen falls on FDA delay
Marketwatch
Monday, October 19, 2009 - 10:27am
tags:
Amgen, drug stocks
Wyeth Quits On Relistor; Surprise Victory in First REMS Test Market
InVivo
Monday, October 19, 2009 - 10:02am
tags:
Wyeth, Relistor, Progenics Pharmaceuticals
Facet Biotech's Board of Directors Recommends Stockholders Continue to Reject Biogen Idec's Tender Offer
Yahoo
Monday, October 19, 2009 - 9:58am
tags:
Biogen Idec, Facet Biotech, M&A
5-Star Stocks Poised to Pop: Novartis
Motley Fool
Monday, October 19, 2009 - 9:50am
tags:
Novartis
Delay Undercuts H1N1 Vaccine Campaign
WSJ Online
Monday, October 19, 2009 - 9:42am
tags:
H1N1, swine flu, vaccines
FDA Approves Glaxo's Cervical Cancer Vaccine
NY Times, NY
Monday, October 19, 2009 - 9:40am
tags:
GSK, cervical cancer, HPV, vaccines, Cervarix, FDA
Amgen says FDA wants more data on Prolia as a bone loss treatment, delaying potential approval
Yahoo/AP
Monday, October 19, 2009 - 9:19am
tags:
Amgen, FDA, Prolia, osteoporosis
AstraZeneca Offers Buyouts To Its Entire Sales Force
Pharmalot
Monday, October 19, 2009 - 9:18am
tags:
AstraZeneca, layoffs
Pfizer Pays Record $1.3 Billion Penalty for Drug Misbranding
Bloomberg
Monday, October 19, 2009 - 9:16am
tags:
Pfizer, Bextra, criminal fines
Human Genome Sciences gets milestone payment for development of hepatitis C drug Zalbin
Yahoo/AP
Monday, October 19, 2009 - 7:56am
tags:
hepatitis C, Zalbin, Novartis, Human Genome Sciences
Forest Labs, Cypress say Savella helped symptoms of fibromyalgia in late stage trial
Yahoo/AP
Monday, October 19, 2009 - 7:48am
tags:
fibromyalgia, Forest Labs, Cypress Bioscience, Savella

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.